pro.oxfordclub.com Open in urlscan Pro
192.135.136.168  Public Scan

Form analysis
1 forms found in the DOM

POST

<form action="" id="EmailCapture" method="post"><input class="mvcode" name="MultivariateId" type="hidden" value=""> <input name="NotSaveSignup" placeholder="email" type="hidden" value="False"> <input class="coreg" name="CoRegs" type="hidden"
    value="">
  <div class="form-group"><input class="email form-control" id="email" name="email" placeholder="Enter Your Email" required="" type="text" value=""></div>
  <!--  you can add passthrough class to completely override leadgen for this form 
				  	if leadgen is elsewhere on the page-->
  <div class="center"><input class="leadSubmit btn btn-primary EmailSubmit" data-portrait-position="clickpop-orderform-button" data-portrait-type="order-form-link" name="submit" style="white-space: normal;" type="button"
      value="Continue to Secure Registration Page"></div>
</form>

Text Content

BRAND-NEW TEK TALK:


HOW AN UNKNOWN KANSAS WELDER ENDED UP ON THE FORBES RICHEST LIST...


HE DIDN’T START A BUSINESS... WIN THE LOTTERY... OR INHERIT A FORTUNE... BUT ANY
AMERICAN CAN MAKE ONE MOVE IN LESS THAN 3 HOURS – AND FOLLOW IN HIS FOOTSTEPS.
HERE’S HOW...

Click for sound











YES! I Want the Details on the #1 AI Stock
Read the Transcript

Hi, I’m Alexander Green, Chief Investment Strategist of The Oxford Club.

And today, I want to tell you a remarkable true story.

It involves a man named Stewart from Kansas.

At first, there was nothing particularly interesting about Stewart’s story.

When he graduated from the University of Kansas, he went to work in his family’s
welding business.

It was a fine career. Enough to keep food on the table.

But over the years, competitors began eating away at the company.

Profits dwindled.

And by 1980, the survival of the family business was in serious jeopardy.

And this is where a rather normal American story suddenly turned into an
extraordinary success story.

You see... it was at this time that Stewart picked up a book.

A book titled The Money Masters by John Train.

The book detailed the investment strategies of some of the greatest investors of
all time... like Benjamin Graham, John Templeton and Warren Buffett.

Stewart read the book... and inspired by what he read... he decided to make a
purchase that would change his life forever.

He bought 40 shares of Warren Buffett’s Berkshire Hathaway stock at $265 per
share...

Today, with Berkshire trading at over $500,000 per share, those 40 shares alone
are worth over $21 million.

But that’s just a fraction of Stewart’s net worth.

You see, he didn’t stop at just 40 shares.

A month later, Stewart bought 60 more...

Then another 200.

Eventually he bought over 5,800 shares... all for less than $500 per share.

Stewart’s investment made him a billionaire... worth $2.8 billion.

His family’s business and financial future were secured forever.

He’s now on the Forbes list as one of the richest people in the world.

The list is usually filled with entrepreneurs who spent decades building
businesses... plus some who inherited fortunes.

But there is Stewart, the welder from Kansas, right on the list... 

All because he did nothing more than buy one single stock.

Why do I tell you this story?

Because while investment professionals usually tell you that diversification and
index funds are the path to a wealthy retirement...

The truth is...

A modest investment in the right stock can provide you with all the wealth you
need for the rest of your life.

Now, many might say that Stewart got lucky... and that finding that one great
stock can’t be done again.

But here’s what nobody really talks about.

Tens of thousands of Americans have become millionaires thanks to just one
stock.

It happens ALL THE TIME.

I should know.

Because I’m one of them.

I’ve personally done it three times. I invested in Apple in 1996 and 1997. I
bought Netflix in 2005. And I bought Amazon in 2005 and 2006. And I still hold
every share of these stocks.

These were modest investments.

But they changed my life forever.

Amazon is up 7,600%. Netflix is up 26,600%. And Apple is up a stunning
102,000%... meaning every $100 turned into more than $100,000.



That’s the power one single great stock can have in your portfolio.

So I want you to think about this for a minute.

Imagine buying one single stock in the next three hours... and changing the
trajectory of your family’s future forever.

It can happen.

But the question is...

How do you find the right stock?

If your goal is to be the next Stewart... to find one stock where just a few
thousand dollars turns into a fortune...

How do we go about identifying the stock with the best chance to get us there?

That’s what I’m going to share with you today.

You see... I’ve found the next stock that I believe has just as much potential
as (perhaps more than) Berkshire Hathaway, Apple, Netflix or Amazon.

In fact, it could be even bigger than any of those when all is said and done.

Why am I so confident?

For one, it’s involved in the most important new cutting-edge technology in the
world.

In fact, it may be involved in the most important new technology – EVER.

We’re talking about the entire history of mankind!

But don’t take my word for it.

Google’s CEO, for example, has said...

> This is “the most profound technology humanity is working on – more profound
> than fire or electricity or anything we’ve done in the past.”Google CEO Sundar
> Pichai

Bill Gates says...

> This is the most revolutionary technology he has seen in decades, on par with
> computers, cellphones and the internet.Bill Gates

Mark Cuban even predicts that...

> “The world’s first trillionaires are going to come from somebody who masters
> [this technology].”Mark Cuban

I’m talking, of course, about the sudden explosion in artificial intelligence,
or AI.

As Stanford professor and entrepreneur Steve Blank says...

> “AI has just transformed every industry and every business. Every possible
> piece of commerce and enterprise... is going to be reinvented in the next
> year.”Stanford Professor and Entrepreneur Steve Blank

The company I’m going to tell you about today I believe will become the most
important AI company in the world over the coming years.

It’s currently a small company – with a market cap of less than $1 billion. And
a stock price under $10.

That’s just a bit smaller than the size of Apple in the mid-’90s... before it
went on to rise over 1,000 times in value.

And this stock has every chance of being just as successful... or even more so.

Why?

Because the company is in the process of developing a product that will help
virtually every single person on the planet.

The market they are targeting is worth approximately $12 trillion globally.

It’s more than double the size of the oil and gas industry...

It’s bigger than tech... telecommunications... food... commercial real estate
and more.

This company is at the center of a technological advancement that has the chance
to supercharge this $12 trillion industry in a way “no one has ever seen,”
according to MIT Technology Review.

MIT says their version will be 1,000 times faster than current methods.

Technology expert Peter Diamandis says...

> This technology “can accomplish with 50 people what [the current] industry can
> barely do with an army of 5,000.”Technology Expert Dr. Peter Diamandis

Jobs that used to take decades and cost over $10 billion... will now be done in
months and at a fraction of the cost.

Like Bill Gates has said... this AI space is just as big as, if not bigger than,
computers, cellphones and the internet.

And for this one company, it could result in blockbuster earnings quarter after
quarter.

I’m expecting future sales and profits won’t be in the tens of millions... or
even the hundreds of millions.

We’re looking at the potential for billions of dollars in future sales!

In short, if you want to find that one winning stock – just like Stewart from
Kansas – this company meets every metric you could want in a Perfect Stock.

And most astonishing of all, it trades for less than $10 today...

Why so cheap?

Like the other stocks I’ve talked about, it’s at the very beginning of a
brand-new industry.

This is like investing in Apple at the start of the smartphone revolution... or
Netflix when streaming first began... or Berkshire Hathaway when Warren Buffett
revolutionized the approach to investing.

The only problem is... very few Americans have any idea this company exists.

I estimate that there’s a less than 1-in-50,000 chance that you own the stock or
have even considered owning it.

But that is about to change in a big way.

Some of the biggest power players in the world are targeting this stock for
massive gains going forward.

Bill Gates, for example, is putting his money where his mouth is. His foundation
has loaded up with nearly 1.6 million shares of this company.

SoftBank Group, one of the biggest tech investment firms in the world, went big
with 5.6 million shares.

BlackRock now owns at least 1.2 million shares.



With the biggest, most powerful investors in the world moving in, I don’t
believe this company will remain unknown and inexpensive for long.

So please stick with me for the next few minutes.

 * I’m going to explain this company’s technology to you in full.
 * I’ll show you how it is using cutting-edge AI technology to change the world
   forever.
 * And I’ll explain why I believe this company has the chance to be the #1 AI
   company in the next few years.

As the story unfolds, people across America will be buzzing with excitement as
they finally discover the astonishing upside potential and secret identity of
this breakthrough company.

But you could already be on your way to a dream retirement... all because you
scooped up this obscure stock for less than $10 today.


WHY SHOULD YOU LISTEN TO ME?

Now... before I give you the full details, let me start by addressing the most
important question you’re probably asking yourself right now.

“Why should you listen to me?”

So let me start by introducing myself.

As I said, my name is Alexander Green and I’m the Chief Investment Strategist at
The Oxford Club.

We’re one of the oldest financial clubs in the nation... with more than 187,000
Members from all walks of life.

Our Members include accountants, doctors, Ph.D. economists, teachers,
scientists, engineers and entrepreneurs.



And my mission is to help every Member grow and protect their wealth.



Normally, we do this through a diversified mix of investment recommendations.
These have helped our Members earn exceptional returns on their money.

In fact, when comparing our average trade vs. the S&P from 1999 to November
2022, it beat the market by 158%.

Keep in mind, 92% of active fund managers DO NOT even beat the market.

Yet our average trade has beaten the market for over two decades.

However... today I’m going to reveal a dirty little secret of the investment
world.

The truth is...

Sometimes too much diversification is not a good idea.

Now, I’m not saying you should put all your money in one stock.

I invest in a wide range of stocks myself.

What I am saying is... when you find a single stock that’s truly special, you
can in fact retire on that one stock... even with a rather modest investment.

As Warren Buffett points out...

> When you “know the business... you understand it, the price is right, the
> people are right... then you take your thumb out of your mouth and barrel
> in.”Warren Buffett

Over the first two decades of the 2000s, I either personally bought or
recommended four of the six best-performing stocks in the entire market.

In fact, during my time as the Chief Investment Strategist at The Oxford Club,
we’ve found a number of stocks that could deliver life-altering gains.


WE’VE CALLED MANY OF THE BIGGEST STOCK WINNERS OF THE PAST 15 YEARS

For example, back in January 2002, we published our Annual Forecast Issue and
highlighted an up-and-coming coffee company. You might have heard of it. It’s
called Starbucks.

“The company plans on opening thousands of more stores across the world in the
years ahead,” we wrote. “Think McDonald’s for coffee.”

Split-adjusted, the company was just $5 back then.

Today, it’s around 1,849% higher.

Later on we recommended Celgene.

It’s a biotech that fights cancer.

Here’s just a piece of what we published:

“With Celgene, investors have a strange and wonderful opportunity. The company
is a cutting-edge, new-medicine firm. However, unlike just about any other
medical innovator at this stage, Celgene’s speculative ‘new’ compound is already
approved by the FDA. And the company is already profitable.”

One of our Members invested $25,000 in Celgene.

Here’s a note he wrote to us.

> “What I still hold is now up 2,440%, and that’s having sold off my original
> $25,000 investment and $300,000 in profits. That $25,000 investment generated
> more than $800,000 in total (2003-2017), and I’m still holding a good chunk of
> it.” Oxford Communiqué Member

But perhaps the most relevant example I can give you is a company called
Intuitive Surgical.

Intuitive reminds me more of the company I’m recommending today than any other.

Back when it was trading for less than $25 per share in 2004, I wrote this:

“It holds a monopoly position in surgical robots. As a result, sales and
earnings are making a dramatic turn northward. Gross profits are a whopping
63.2% of sales. And recurring revenues are already more than doubling. Clearly,
this is a stock with a great deal of upside potential.”

One of our members, Dave F., bought 1,000 shares with an investment of $25,000.

Here’s a screenshot of his buy after he saw my report.

And here’s the stock chart since Dave bought.

It’s a stock that’s gone virtually straight up.

Even if he didn’t hold on for the entire ride, there was opportunity to capture
some insane profits.

It was one of the five best-performing stocks in the entire market from 2000 to
2020, beating even Apple!

Sean Connors is another member who made big money on Intuitive Surgical.

In 2019, he said...

>  “I bought and sold it five times. And I made $1.2 million on the fifth
> time.”Sean Connors

From 2004 to 2019, Intuitive Surgical gained an incredible 6,000%. And Sean’s
using this money to create generational wealth for his family.

He’s set it up so his grandkids will get “some serious money” once they turn 40
years old. 

That’s what can happen if you buy the right stock.

Just one can secure your family’s future.

Now, these are some of the best testimonials we received from subscribers who
took my recommendations and turned them into big wins for their families.

Not every subscriber hung on for the whole ride... Some surely sold along the
way when we recommended taking profits.

But the message is clear...

If you want the true dream retirement... and you’re worried that you haven’t
saved enough... it’s not all about diversification.

It’s about finding that one stock that’s created a new cutting-edge technology
or product that is now set to change the world.

And today, I’ve found what I’m convinced is the next great breakthrough company.

I’ve never seen a firm better suited to fund American investors’ retirements.

It’s cheap, at less than $10 per share.

It’s virtually unknown to most investors.

Sales could go to billions of dollars.

And in the future, it could become the most valuable AI company in the world.

I believe it is the #1 AI Stock.


THEY’RE DOING EXACTLY WHAT INTUITIVE SURGICAL DID 20 YEARS AGO

In order for you to understand how big this opportunity is... I want to go back
for a second and explain why I recommended a company like Intuitive Surgical way
back in 2004 before it became one of the best-performing stocks of the century.

Here is what I wrote about the company and its da Vinci surgical robots when I
added it to our portfolio:

Robotic surgery is now being performed at hundreds of hospitals in the U.S. and
around the world.

The benefits are numerous: reduced trauma to the body, less anesthesia, less
blood loss, less post-operative pain, less risk of infection, shorter hospital
stays, less scarring and faster recovery...

Intuitive Surgical is the world leader in operative surgical robotics…

The da Vinci Surgical System takes minimally invasive surgery to the next level.
With only a keyhole incision and a skilled surgeon at the controls, it can
perform intricate operations that traditionally are done by opening up the
patient…

The da Vinci system makes more precise cuts and causes less bleeding.

In a recent study comparing robot-assisted surgery to traditional surgery,
University of Michigan surgeons found that patients who had robot-assisted
surgery recovered more quickly and had fewer scars...

Already, da Vinci can perform more than 100 different types of procedures, from
repairing hernias to removal of the prostate to coronary bypass grafts.

It is the one and only proven surgical robot in the world...

As a result, sales and earnings are making a dramatic turn northward... Clearly,
this is a stock with a great deal of upside potential.

At the time, Intuitive Surgical had sold only 250 of its machines... generating
revenue of around $1.3 million for each one.

Today, there are more than 7,500 da Vinci surgical robots operating in 70
countries.

Sales have topped $6 billion annually.

As Business Insider reported, the company became one of the five best-performing
stocks of this century.

Over the past two decades, the stock has continued increasing, and that gain has
gone from 6,000% to a staggering 18,500%.

And it’s all because the company found a way to use technology and machines to
enhance the capabilities of human beings.

And that is exactly what the new company I’m telling you about today is doing.


THE MEDICAL COMPANY USING AI TO RADICALLY SPEED UP THE DISCOVERY OF BREAKTHROUGH
TREATMENTS

It is also a medical technology company... founded in England by a doctor in
biophysics from the University of Oxford.

And like Intuitive, this company is set to revolutionize medicine.

The founder of the company spent a decade at Pfizer learning the inner workings
of the pharmaceutical industry before coming up with a brilliant idea.

What if he could use artificial intelligence to create more effective drugs...
with less side effects... and bring them to market faster than ever?

AI enables computers, robots and other connected devices to mimic the
perception, learning, problem-solving and decision making of the human mind.

This allows computers to perform specific tasks with breathtaking speed and
accuracy – and without human intervention.

And one area with unprecedented promise... is using artificial intelligence to
help scientists develop new drug treatments for diseases.


THIS COMPANY COULD SAVE BILLIONS OF LIVES AND BILLIONS OF DOLLARS

In the past, developing a new drug was extremely time-consuming, expensive and
risky.

90% of all drugs fail in trials.

It takes an average of 10 years to reach the market with a drug and costs
between $2.5 billion and $12 billion to get there.

Why is it so costly and difficult?

MIT Technology Review says it’s a system of “trial and error.”

Scientists spend countless hours testing thousands of molecules... hoping that
one will show promise.

But the problem is...

There are so many possible molecules that scientists can only test a tiny
fraction of the possible candidates.

Consider this question posed by MIT...

> “What fraction of these molecules have potential drug-like traits that can be
> used to develop lifesaving drug treatments? Millions? Billions? Trillions? The
> answer: novemdecillion, or 1060.”MIT

That’s a 1 with 60 zeroes behind it!

In other words, with our current process, scientists are leaving the vast
majority of treatments on the table.

Through trial and error, they are wasting billions and taking years to find
anything remotely effective.

Well... just like Intuitive Surgical completely disrupted surgery with its da
Vinci surgical robots... AI is changing the drug discovery process as we speak.


AI MODELS DISCOVER DRUGS 1,000 TIMES FASTER THAN CURRENT METHODS

As technology expert Dr. Peter Diamandis, whose work I read every day, puts it:

> “What if we could generate novel molecules to target any disease, overnight,
> ready for clinical trials? Imagine leveraging machine learning to accomplish
> with 50 people what the pharmaceutical industry can barely do with an army of
> 5,000. Welcome to the future of AI and low-cost, ultra-fast, and personalized
> drug discovery.”Technology Expert Dr. Peter Diamandis

In short, AI can now take massive datasets of potential molecules and then
analyze them to find the ones most perfectly matched to fight a disease.

And the speed and accuracy are breathtaking.

According to one report in The Independent...

> MIT’s artificial intelligence can identify effective drug possibilities 1,000
> times faster than the traditional method.The Independent

The Wall Street Journal reports that...

> “The time required for the early stages of drug discovery could shrink from
> years to months.”The Wall Street Journal

They say the approach could not only boost the effectiveness of current drugs
and drug candidates... but could also lead to...

> “Never-before-seen molecules that could treat diseases like pancreatic cancer
> or ALS.”The Wall Street Journal

These are diseases for which scientists haven’t been able to find effective
cures.

MIT Technology Review reports that AI is dreaming up drugs that “no one has ever
seen.”

But AI could do the job ultra-fast, with pinpoint accuracy, and at far less
cost.

As Hospital News confirms...

> “This could reduce in principle the time between concept and coming to market
> of new drugs by years and decrease production costs by $100s of millions.”
> Hospital News

You can see why Mark Cuban says the first trillionaire is going to come from
somebody who masters AI.

The profit potential is off the charts.

Instead of searching for a needle in a haystack...

AI goes through huge datasets to find the BEST molecules to provide effective
treatments at speeds we could not imagine previously.

And there is one company in particular set to dominate this new AI approach to
medicine.

The company I’m telling you about today is the first AI platform to improve
treatment outcomes for cancer patients.

It is the inventor of the world’s first AI-designed drug to enter clinical
trials.

And this isn’t just a dream for the future.

The company is already saving lives now... like Paul, an 82-year-old cancer
patient.


PAUL, AN 82-YEAR-OLD CANCER PATIENT, THOUGHT HE WAS FINISHED... UNTIL HE WAS
CURED USING AI

Paul had a form of blood cancer that was aggressive and difficult to treat.

He went through six rounds of chemotherapy.

They tried an assortment of cancer drugs one by one, but with no luck.

Much of this harmed Paul’s healthy cells, and he became more and more frail.

All six rounds of treatment failed.

That’s when doctors turned to the company I’m telling you about today.

They used AI to analyze Paul’s disease for the best possible available
treatment.

The system combed the data and shot out an answer... a drug doctors hadn’t
considered at all.

And it worked.

Within two years, Paul’s cancer was completely gone.

After that success story, the company moved forward with a scientific study.

It tasked AI with coming up with treatment plans for dozens of cancer patients
in which chemotherapy had already failed twice.

The old way didn’t work for them.

But using AI, this company was able to identify a drug that was effective for
more than half of them.

And keep in mind, this is only in the early stages of this technology.

Moving forward, history tells us it will improve at an exponential rate...
getting better and better every year.

In fact, I believe it will completely revolutionize the entire pharmaceutical
industry... with this one company leading the charge.

As a result, the biggest companies in the world are lining up to work with them.


NOW THAT THE TECHNOLOGY IS WORKING, THE BIGGEST COMPANIES IN THE WORLD ARE
LINING UP TO WORK WITH THIS NEW AI COMPANY

For example, the French drug giant Sanofi entered into a $283 million
partnership with the company a few years ago.

But now they are going bigger...

Sanofi recently agreed to pay the company up to $5.2 billion to develop 15
experimental oncology and immunology drugs.

The company will receive $100 million upfront as well as milestone payments from
successful treatments.

And that’s just one of many projects in the works. The latest is a collaboration
with Merck on three potential best-in-class drug targets. The deal could be
worth up to $674 million.

It’s also signed a major $1.2 billion partnership with Bristol Myers Squibb, one
of the biggest pharmaceutical companies in the world.

The company has a partnership with Japan’s huge pharma company Sumitomo
Dainippon Pharma.

Together they brought an AI-designed drug to clinical trials in one year...
compared with the five it normally takes.

The company is working with Rallybio, an American pharma company, on rare
diseases.

And yet another partnership with Apeiron Therapeutics is developing a treatment
for ovarian cancer.

The president of Apeiron had this to say about our company:

> “[It] is clearly the leader in AI-driven drug discovery, and we have witnessed
> this firsthand in our collaboration so far. We have been incredibly impressed
> by the combined power of the AI design and use of patient data to optimize and
> select molecules that are more likely to give positive effects in the
> clinic.”President of Apeiron Therapeutics

In short, the biggest pharma companies across the globe are lining up to get
access to this company’s patent-protected technology.

As Pharmaphorum points out, this makes this company...

> “One of the most well-funded players in the AI discovery
> category.”Pharmaphorum

But listen, it’s not just their partnerships with Big Pharma.

The company itself is using AI to develop dozens upon dozens of treatments.


THE COMPANY’S EXPANDING PIPELINE COULD SET IT UP FOR BILLIONS IN FUTURE REVENUE

For example...

 * The company is working on new treatments for solid tumors, including
   ovarian and breast cancer tumors.
 * It published clinical results in Cancer Discovery that highlight the first
   AI-supported platform to guide the treatment of patients with advanced blood
   cancer.
 * It completed the acquisition of Allcyte, integrating that company’s tissue
   platform into its own drug discovery operations.
 * It launched its third collaboration – worth $70 million – with the Bill &
   Melinda Gates Foundation to create a portfolio of up to five antiviral drugs.
 * Its strong balance sheet is in a great position to fund AI-designed molecules
   going forward, with over $600 million in cash in the bank.
 * It opened a 21,000-square-foot expansion of facilities at The Oxford Science
   Park, expanding its capacity and efficiency for developing new AI drugs.
 * There’s also a 26,000-square-foot laboratory that will focus on the
   automation of chemistry and biology to accelerate drug discovery.
 * It opened a new 50,000-square-foot precision medicine center in Vienna,
   Austria.

This is a pharmatech company that is setting up to become one of the biggest and
most powerful pharma companies in the world.

And for shareholders, that could spell massive profits.


STOCKS THAT DEVELOP EFFECTIVE MEDICAL TREATMENTS RESULT IN SOME OF THE BIGGEST
GAINS OF ALL TIME

Putting a few dollars in a great medical stock can have a dramatic effect on
your portfolio.

Look at a company like Amgen.

Thanks to its drug treatments for kidney disease, rheumatoid arthritis, cancer
and more... the company has seen its stock go from $1 in 1990 to over $260.

A simple $10,000 investment would be worth $2.6 million today.

Abbott Laboratories is another one.

Thanks to products like Pedialyte, Similac, Ensure, Glucerna and more... the
company has seen its stock go up 200-fold since 1980.

A $10,000 investment would have turned into more than $2 million.

That’s more than $49,000 in profit for each year you would have held it.

But here’s the thing...

With biotech, it doesn’t have to take nearly that long.

For example, I gave a presentation on the company Tandem Diabetes Care in 2018.

It had just developed a revolutionary new insulin delivery system.

At the time, its stock price was less than $4.

But just one year later, it was over $74... a gain of more than 1,700% in less
than a year.

And here’s what’s truly incredible...

Tandem’s technology only targeted a small segment of the population with
diabetes.

What this new AI company is doing could alter the entire $12 trillion global
healthcare market.

We’re talking about a bigger industry than tech... oil and gas... or
communications.

That’s why I believe this company could become one of the biggest and most
powerful of all time.

And it goes well beyond developing pharmaceuticals...


THIS TECHNOLOGY CAN BE USED TO SOLVE AN UNTOLD NUMBER OF PROBLEMS!

Scientists are using AI to do all kinds of amazing things right now.

For example, one group of researchers has used AI to create new antibiotics
capable of killing off bacteria found in hospitals that cause pneumonia,
meningitis and other serious infections.

These infections are especially problematic for wounded soldiers.

James Collins, professor of medical engineering and science at MIT, says...

> “This finding further supports the premise that AI can significantly
> accelerate and expand our search for novel antibiotics.”James Collins

Scientific American just released a report showing that...

> AI can be used to “detect early signs of cancer” and assess cardiovascular
> risk from a retinal scan.Scientific American

The Wall Street Journal writes that the same drug discovery technique can be
applied to many industries.

> For example, it could be “used to produce better enzymes for degrading
> plastics, treating wastewater and cleaning up oil spills, among other
> environmental applications.”The Wall Street Journal

With all the potential uses of this technology, the company I’m recommending now
could become one of the most important companies in the world.

It’s that big an opportunity.

But now is the time, as the stock is trading for less than $10.

This is one of those “Stewart from Kansas” moments... when buying just one stock
could ultimately secure your financial future forever.

And let me be clear about something important. I am NOT suggesting that you put
your retirement money into this stock. 

There are no guarantees that this tiny stock will turn into the next legendary
winner.

It has that kind of potential, but there are always risks with investing.

I never recommend anyone invest more than they can afford to lose.

That’s why... what I'm recommending is that you put a MODEST amount of money in
this stock and then sit back, leave it alone and let it compound in value for
years and years. That is how real fortunes are made.

But in order to see the biggest return, it’s key that you get in soon.

Artificial intelligence is the kind of disruption we wait our whole careers for.

If you miss AI changing the face of medicine... there’s no going back for a
redo.

These kinds of disruptions happen once... and then they are gone.

Because here’s the thing...

This stock may not be available cheap for long.


THERE IS A HUGE LINEUP OF CATALYSTS COMING

One of the things that make biotechs so appealing is the number of catalysts
they produce that can send their stocks soaring very fast.

ImmunoGen is a great example of this.

I recommended it to my subscribers on May 11, 2023.

The very next day – on May 12 – the company announced positive Phase 3 data on
an ovarian cancer drug.

This wasn’t even an FDA approval.

Yet in just 24 hours, the stock soared over 144%... making it the #1 performing
stock in the entire market.

A month later, it was up 230%.

That’s how fast biotechs can move when big catalysts hit.

Catalysts can include the announcement of a partnership, the beginning of human
trials, positive trial data, FDA approval and much more.

And what I love about the stock I’m telling you about today is it is set up to
make headline news over and over going forward.

The company has drugs in their pipeline to treat head and neck cancers,
colorectal cancer, and breast, ovarian, and pancreatic cancer.

One of their AI-designed compounds just hit the clinical development stage...
plus two more are coming right behind it.

The company recently announced a brand-new potentially first-ever immunology and
inflammation candidate in partnership with Bristol Myers Squibb.

A month later, there was another announcement of a collaboration with the
University of Medicine in Berlin to predict hematological cancers.

As the chief executive and founder of the company says...

> Their “pipeline of wholly owned and partnered drug candidates is progressing
> rapidly.”Chief Executive and Founder

As you can see, the number of upcoming catalysts is likely off the charts.

Which is why...

The biggest investors in the world are moving in quickly.


THE BIGGEST INVESTORS IN THE WORLD ARE MOVING IN

The company has flown mostly under the radar until now...

It’s almost completely unknown to the general public. (Trust me, I bet neither
your broker nor anyone else has ever recommended the stock to you.)

And that’s very good news for us.

Because when you can buy a truly great business while it’s still unknown and
cheap, that’s when the gains can be truly spectacular.

And that’s what the most powerful investors in the world are doing now.

BlackRock now owns at least 1.2 million shares.

Softbank Group, one of the biggest tech investment firms in the world, went big
with 5.6 million shares.

And as I mentioned, the Bill & Melinda Gates Foundation now owns 1.6 million
shares of the company.



They believe in it so much, they are actually working with it to develop five
antiviral drugs directly.

They are leading a core group of more than a dozen mutual funds and trading
houses that are betting big on this stock while it’s less than $10.

If you’re looking for the right stock... the one that could change your life,
like when Stewart bought Berkshire Hathaway... this is your chance.

And you don’t have to bet the farm on one single stock, either. In fact, please
don’t do that.

When you get in for just a few dollars per share, just a small sum can be
game-changing.

That’s been my recipe for the biggest successes in my own portfolio.


I’VE “RETIRED” ON ONE STOCK... THREE SEPARATE TIMES

The truth is... on a few rare occasions in my life... I’ve found a stock so
innovative, so brilliant in concept and with so much profit potential... that
I’ve bet on that single stock.

I’ll never forget the day I saw one of those red envelopes with “Netflix”
written on it at a friend’s house.

I was immediately curious.

Keep in mind, this was more than 15 years ago.

My friend was already a Netflix evangelist. He gushed about the online video
rental company that delivered movies right to your doorstep and DID NOT charge
late fees.

He was a rabid customer. But I decided I’d become something different: an early
investor.

It instantly clicked for me.

And I immediately bought shares.

I didn’t put in that much. Just over $5,000. After all, Netflix was still
trading for a split-adjusted $2 back then.

But today, with Netflix trading for over $400, I still hold every share.

I’ve never sold and I don’t plan to.

Without bragging about exact figures, let’s just say that stock alone is more
than enough for me or anyone else to retire on.

The same thing happened for me with Amazon.

Back in the early 2000s, the user interface and customer service on its
e-commerce website were so good, I knew this was one of those companies that
could fund an entire retirement all by itself.

So I picked up a few shares while Amazon was still trading around $35.

By the beginning of 2022, Amazon was trading at more than $3,500 per share...
before going through a 20-to-1 split. My investment could pay for my kids’
retirements.

And before Amazon and Netflix, I first did it with Apple.

Apple’s products were truly groundbreaking. So in 1996 and 1997, I picked up
$5,700 worth at less than a split-adjusted 20 cents per share.

And I still hold them today.

When Apple hit a new high of $195, it was up more than 1,000-fold. My investment
may someday pay for my grandkids’ retirements!

The point is...

I’ve done well with my diversified portfolio, but my retirement has been built
on finding single stocks like Netflix, Amazon and Apple.

And I’ve had big wins on many more stocks, like Costco and Boston Beer Company.

My success didn’t require betting a fortune on any one of these plays. In fact,
I never recommend betting it all on one stock. Please understand that.

I’m a big believer that modest investments in a few companies with great
potential are the recipe for building wealth.

Some might not work out, but the ones that do can change everything.

And I believe the company I’ve told you about today represents one of those
“Perfect Stock” moments.

Its technology is set to completely revolutionize our world.

Investors everywhere will soon be talking about this company.

That’s why the time is now.

The stock is still available for less than $10.

But soon, you may have to pay a multiple of this price.

And who knows how high it could go in the next 10 years?

Will it go 17 times higher in a year, like Tandem Diabetes Care?

Will it go over 19-fold higher over 15 years, like Celgene did before it was
bought out for billions?

Will it go 100 times higher over 20 years, like Intuitive Surgical?

Only time will tell.

But a few thousand dollars in this one stock could be the investment that
changes everything.

Only those who move today will have the chance to enjoy the ride.

That’s why I’d like to send you my latest report right now: “The #1 AI Stock:
How to Retire on This Obscure Under-$10 Stock.”

If we were selling this report, it would be valued at $259.

But I want to put the report in your hands today.

 * In it, I’ll lay out everything I’ve uncovered in my in-depth investigation
   into this company.
 * I’ll give you the full rundown of its rise to power and why I believe it will
   generate billions of dollars in revenue in the coming years.
 * I’ll discuss the multiple upcoming catalysts related to its drug trials,
   partnerships, new drug candidates and more.

Most importantly of all, I will give you exact instructions on how to buy this
stock for less than $10.

If you act quickly, you can get in for less than $10, right alongside the Wall
Street pros who are currently loading up on shares.

There are only two paths you can take moving forward.

 * Take a position now while the stock is still cheap. And every time you see
   the company in the news, you can smile, knowing your stock is likely moving
   up.
 * Ignore this opportunity. And every time you hear about the stock on CNBC,
   you’ll cringe at how you missed out – again – on a single stock that could’ve
   helped you pay for your retirement.

Lots of people have found themselves face to face with opportunities like this.

And those who recognized them came away totally changed.

Whether it was Berkshire Hathaway, Apple, Netflix, Celgene, Starbucks, Intuitive
Surgical, Tandem Diabetes Care, ImmunoGen or any of the other stocks I’ve
mentioned today...

Finding that one great stock is the answer.

But you have to get some skin in the game or you won’t have a chance.

And that’s why I’m spreading the word to you today.

I’d like to get my report “The #1 AI Stock: How to Retire on This Obscure
Under-$10 Stock” into your hands right away.

This stock is as good as any I’ve seen – and that includes Intuitive Surgical
and Celgene.

It could be the path to your dream retirement.

The only question left to ask yourself is...


WHAT WOULD YOU DO IF YOU HAD A MULTIMILLION-DOLLAR PORTFOLIO?

Live in the countryside like Dave, the Oxford Club Member who bought Intuitive
Surgical?

Try your hand at writing a novel?

Get a beach house for family vacations?

Give to your favorite charity?



Or finally just sit back and enjoy life without any concerns about money?

For me, knowing I have my retirement paid for makes everything sweeter.

Taking my son to play golf... playing a round of tennis with my wife...
traveling to see bands and musicians I’ve always liked...

Life is just better without money hassles.

And I believe our new AI stock will help you get to that worry-free life.

All the details are in our special briefing “The #1 AI Stock: How to Retire on
This Obscure Under-$10 Stock.”

I can tell you how to get it at the end of this presentation.

But I’m not going to stop there.

You see...

This AI stock is one of the best I’ve ever uncovered.

But I’ve seen others that have 1,000% potential. I call them 10-baggers – stocks
that rise tenfold or more.

This can happen over the course of a decade... but in rare cases it can even
happen in a year, as it did with Tandem Diabetes Care.

In order to help our Members get the chance to lock in more 10-bagger stocks, I
created a speculative model portfolio of stocks that are cheap and offer
tremendous growth potential.


SPECIAL BONUS #1: “TEN-BAGGERS OF TOMORROW: THE OFFICIAL PORTFOLIO GUIDE”  
(VALUE: $139)

When I first announced our model portfolio at a special Members-only event in
Stowe, Vermont... one of the first stocks I talked about was Applied
Optoelectronics.

At the time, it was trading for just over $11.

Exactly one year later, it was up to $95!

This is the type of stock I’m including in my Ten-Baggers of Tomorrow Portfolio.

I’ve outlined my strategy and the key characteristics to look for in my report
“Ten-Baggers of Tomorrow: The Official Portfolio Guide.”

I can have it in your hands as soon as this presentation is over.

Plus, there’s another model portfolio I want to give you access to – our Oxford
All-Star Portfolio.


SPECIAL BONUS #2: “THE ‘ALL-STAR PORTFOLIO’ STRATEGY” (VALUE: $99)

In our All-Star Portfolio, we track the trades of the world’s top investors and
share them with you.

Everything you need to know about our All-Star Portfolio strategy is found in
the report.

I want you to receive all three reports I’ve promised so far, a $497 value. But
I don’t want you to pay one cent for any of them.

You can receive everything I’ve promised just by joining me in my monthly
newsletter, The Oxford Communiqué.


A COMMUNITY OF FREEDOM SEEKERS...

The Oxford Communiqué is a letter I put together to connect with wealth builders
all over the country who care about their families and recognize the true value
of money...

Freedom.

Money is the ability to quit working if you want to...

It’s the ability to live in a fully paid-off home in a safe community...

To travel to see your family whenever you want...

To help your children and grandchildren succeed...

To start a business...

To buy a second home at the beach...

The reason to pursue great wealth is to give yourself the freedom to do these
things.

And that’s my sole goal when I write the latest edition of The Oxford
Communiqué each month – to help our Members achieve true freedom by increasing
their retirement wealth.

With each monthly issue of the Communiqué, I’ll share all my insights on the
economy, interest rates, business developments and, of course, my favorite
stocks with the most upside potential.

I’ll explain why revenues are booming. We’ll watch company insiders to see if
they are buying. And we’ll track Wall Street money flows as they pour into
certain stocks.

I want you to receive my Oxford Communiqué issues as part of everything I’m
offering today.

With more than three decades of experience as a research analyst, professional
money manager and one of the country’s best-known financial writers, I can help
you navigate whatever the markets throw at us in the weeks and months ahead.


WE’VE HELPED OUR MEMBERS THRIVE DURING EVERY MAJOR MARKET DOWNTURN

We’ve managed to avoid or mitigate nearly every major market downturn of the
last 25 years.

For instance... in February 2000, at the height of the dot-com craze, we sent
out a special report to Members, warning...

> “We’re nearing the peak of the greatest speculative mania in all financial
> history. Stocks are at super-stretched valuations. And their inevitable fall
> from grace will not be at all graceful.”The Oxford Communiqué, February 2000

The Nasdaq peaked exactly one month later, in March.

And from there, over the next 2 1/2 years, the Nasdaq lost 78% of its value.

But our Members were safe.

In January of 2008, nearly nine months before the financial crisis struck, we
warned our Members that...

> “The housing market is going through an adjustment like no one has seen in the
> past 100 years.”The Oxford Communiqué, January 2008

Then in 2009, we called the exact bottom of the market. I sent out a message to
Members that read...

> “2009 will be a terrible year for the economy. But, shocking and surprising
> most investors, it should be an excellent year for the stock market.”The
> Oxford Communiqué, 2009

The stock market went on to jump 65% between the market bottom in March and the
year’s end.

Member Joe Martin of California wrote to tell us he made more than $1.3 million
thanks to our market calls over the next four years alone.

> “The bottom in 2008 was $1.4 million. Yesterday (2012) I was at $2.7 million.”
> – Joe Martin

We’ve received many stories like this over the years from Oxford
Communiqué subscribers...


THOUSANDS OF SUCCESS STORIES

Here are just a few notes reflecting the best success stories at our
organization...

> “Started with $200,000 20+ years ago, now at $3,500,000. Income is roughly
> $125,000 in dividends annually.” David Mason

> “31 recommendations... and only one loss! I am 100% with you.” Charles Benson

> “Reader for 10 years. I started with $150,000. Today I have $3.5 million
> despite all my personal and family expense.” Pat Douglas

> “I started very small with $1,000. Now it's worth over $20,000 in three
> years... generating about $5K to $6K a year thus far... Liam Rogers

> “My portfolio has grown about 200-fold over decades. I can say The Oxford Club
> and Alex have had a significant impact on my life, my best investment
> ever!”Ervin Upshaw

> “I love your service and wish I’d discovered it 20 years ago. That would have
> saved me $500,000.” Sam Langston

Of course, not everyone is going to see such incredible gains, or go on a rare
streak of 30 wins out of 31. That type of performance is exceptional.

And our Members come from a wide range of financial backgrounds.

Some are regular folks with only $10,000 or so to invest... while others are
multimillionaires.

But no matter what your investing level... the key is taking control of your
finances and growing that money now.

And I have no doubt The Oxford Communiqué and the principles we follow will help
you down that road today.

In fact, we’ve even put together three resources to help you succeed.


FIRST ADDED BONUS TODAY: RECEIVE YOUR COPY OF OUR BRAND-NEW “MULTIMILLIONAIRE’S
HANDBOOK”! (VALUE: $129)

Our “Multimillionaire’s Handbook” is loaded with secrets that can help you do
just that.

All told, we share 41 secrets in this book. Each one will help you keep more of
your money... and grow it faster too.

The second bonus I have for you is a book I wrote for Members. A New York Times
bestseller.


SECOND ADDED BONUS TODAY: GET A FREE COPY OF MY NEW YORK TIMES BESTSELLER BEYOND
WEALTH: THE ROAD MAP TO A RICH LIFE! (VALUE: $21)

My book Beyond Wealth shows you how to live a rich life.

I’d like to send you a free copy of Beyond Wealth today. You’ll see how to get
it in just a moment.

And I have one more bonus to add.


THIRD ADDED BONUS TODAY: HD VIDEO SET OF MY MILLIONAIRE-MAKER PRIVATE SESSIONS!
(VALUE: $199)

I’d like to send you the videos of my Millionaire-Maker Private Sessions.

This is a series I’ve recorded and delivered to the Members of our Chairman’s
Circle – the highest level of membership within The Oxford Club.

The series explains in detail how my strategies work... how I’ve succeeded in my
career as an investment analyst... and how you can apply those principles to
your retirement as well.

The videos are in crystal-clear HD.

I suggest watching them and then passing them along to friends, family members,
co-workers, whomever you like.

So that’s three added bonuses today, valued at $349.

I want to send them all to you just for joining our organization.


BECOME A PART OF ONE OF THE MOST PRESTIGIOUS FINANCIAL CLUBS IN THE COUNTRY

As I’ve told you, we are a financial club.

Our newsletter’s motto is “Great profits in the company of good friends.”

Our mission is to help you become wealthier in every aspect of your life.

As soon as you join The Oxford Communiqué, you are a full Member of our Club,
with all the privileges that entails.

You’ll receive...

 * Access to all of our model trading portfolios, including the Oxford Trading
   Portfolio, the Oxford All-Star Portfolio and the Ten-Baggers of Tomorrow
   Portfolio
 * Weekly model portfolio updates with key new information regarding our
   recommendations
 * Oxford Insight emails with behind-the-scenes intelligence from the Oxford
   Club team, as well as The Oxford Club’s global network of associates
 * Reports like “The Oxford Club Guide to Gold” and “23 Cash Rebate Programs
   Hidden in the Tax Code”
 * Password-protected access to the Members-only website, newly designed with a
   more personalized approach for you
 * Personal invitations to our five-star Member events in beautiful locations
   like Whistler, British Columbia, where we held a recent Private Wealth
   Seminar
 * Access to our Pillar One Advisors, including experts in collectibles, real
   estate, tax law, insurance and more.

You’ll also receive every one of the reports, books and special bonuses I’ve
lined up for you today, including...

 * “The #1 AI Stock: How to Retire on This Obscure Under-$10 Stock” (Value:
   $259)
 * “Ten-Baggers of Tomorrow: The Official Portfolio Guide” (Value: $139)
 * “The ‘All-Star Portfolio’ Strategy” (Value: $99)
 * “The Multimillionaire’s Handbook” (Value: $129)
 * Beyond Wealth: The Road Map to a Rich Life (Value: $21)
 * And the HD video set of The Millionaire-Maker Private Sessions (Value: $199)

That’s a set of free bonuses valued at $846.

And yes, once you join The Oxford Communiqué, you will have access to me.

I’ve given investment advice to hundreds of thousands of people over my 35-year
career. Many of our Members have gone from beginner investors to
multimillionaires.

And it’s by identifying great stocks like the ones I’ve talked about today.

I believe the under-$10 AI stock I’ve described will be the next big winner in
the Oxford Club hall of fame.

This company is set to become one of the most profitable in the world. The
number of drugs in development and giant partnerships is off the charts.

If there was ever a chance to retire on just one stock, I truly believe this is
it.

I don’t want anything holding you back.

Which is why I’m giving you the chance to join me with The Oxford Communiqué at
the lowest price possible today.

Clients paid millions of dollars to receive my advice when I worked on Wall
Street. Many considered it the best money they ever spent.

But I gave all that up.

Investment bankers and stockbrokers have too many conflicts of interest.

And once I made my retirement by identifying just a few true breakout stocks, I
didn’t need to work on Wall Street anymore.

That’s why we charge so little for The Oxford Communiqué...

Just $249 for a full year.

It’s as good a deal as there is in the investment world.

After all, we’re crushing the performance of hedge funds that charge clients
tens of thousands of dollars.

Consider Ted Glennon, who was once in your shoes, deciding whether to join The
Communiqué...

He made his money back and then some within his first two weeks.

Ted was blown away after banking $1,020, a 29% gain, on Harvest Energy Trust,
his very first trade.

> "I have $1,020.88 more than I had before. [A 29% gain in 2 weeks.] This is the
> very first trade that I completed since joining The Oxford Club. Thank
> you."Ted Glennon

But having said all that, again – I want everyone to have a chance to share in
our success.

So to make this as easy a decision as possible for you, here’s what my publisher
has decided to do.

I want to give you a risk-free subscription to The Oxford Communiqué today for
just $49 – our absolute lowest price.

And here’s the final kicker.

I’m going to back all this up with a 365-day, 100% money-back guarantee.

MY 365-DAY
100% MONEY-BACK GUARANTEE



You’ll have 12 months to use and review everything I’ve talked about today.
You’ll see how the new AI stock performs.

You can track my Ten-Baggers of Tomorrow Portfolio. You can use any of the
dozens of secrets in “The Multimillionaire’s Handbook.”

No matter how much you make in profits, here is my promise to you...

You can call us up at any time and for any reason over the next year and we will
give you a full 100% refund of your money – no matter what. PLUS, you get to
keep every single thing you received today.

It’s a bold promise.

But that’s how confident we are.

I have to say, I can’t imagine how I could make this offer any better.

This AI stock is without a doubt the best I’ve seen in my career – it has more
potential even than Netflix, Apple, Intuitive Surgical and Celgene.

It’s revolutionizing a $12 trillion industry bigger than tech, oil and gas,
communications, and more.

It’s set to bring down the time needed to create new lifesaving treatments from
years to months.

It’s set to bring down the costs from billions to millions.

As MIT reports, this technology could generate effective drugs 1,000 times
faster than previous methods.

And best of all, the company is going to save the lives of people like Paul, who
had to go through six rounds of chemo before AI found a treatment that worked.

I believe it’s the single most important stock you can own today.

But one last word of warning...

This company is loaded with headline-making catalysts.

I believe it’s going to be in the news regularly going forward.

The biggest investors in the world are loading up in anticipation.

And you should too.

I’ll be tracking it and keeping you posted on every new development... and
you’ll enjoy the ride all the way through.

I sincerely hope you take advantage of this opportunity now... today. 

I’ve heard so many success stories from people who have joined us.

Like the recent one we received from Benjamin McCormick that said...

> “This has been the most fun an old man has had, and very profitable. You have
> the best organization I have ever known. Thanks for being there for
> me.”Benjamin McCormick

Your success story could be next.

We’ve seen how investing early in a company can create millionaires.

I think it’s that big a story, though nothing is guaranteed in the markets.

Again, if this turns out like Intuitive Surgical, it could end up being one of
the great success stories of the coming AI revolution that will dominate the
next 10 years in stocks.

The opportunity to help build a retirement on one stock doesn’t come often.

For me, it took some guts to pull the trigger on Netflix when most people had
never heard of it.

But I bought the stock, and it was one of the great investment decisions of my
life.

I look forward to helping you see the chance to achieve the same experience.

For those watching at home, just click on the big “Yes! I Want the Details on
the #1 AI Stock” button below.

Yes! I Want the Details on the #1 AI Stock

I look forward to you joining our team and achieving your own “Stewart from
Kansas” moment.

Thank you for your time, and congratulations. Welcome to the Club.

Sincerely,

Alexander Green
Editor, The Oxford Communiqué
September 2023

Yes! I Want the Details on the #1 AI Stock

© 2024 The Oxford Club, LLC. The Oxford Club is a financial publisher that does
not act as a personal investment advisor for any specific individual. Nor do we
advocate the purchase or sale of any security or investment for any specific
individual. Markets have inherent risks and there can be no guarantee of future
profits. Likewise, our past performance does not assure the same future results.
All the recommendations communicated to members during the life of this service
may not be reflected in this presentation. The stated returns may also include
option trades. We will send all our members regular communications with
specific, timely strategies and updated recommendations; however, you should not
consider any of the communications by our company and employees to you
personalized investment advice. Note that the proprietary recommendations and
analysis we present to members is for the exclusive use of our membership. Sep
2023.

 
✕


WAIT!

This #1 AI stock is in perfect position. It is using new AI technology to
develop drug treatments faster than ever. And it's signing major deals in the
process.

Up to $5.2 billion with French drug giant Sanofi… a new collaboration with Merck
worth up to $674 million… and a $1.2 billion partnership with Bristol Myers
Squibb.

For a company worth less than $650 million… these have the potential to launch
the stock higher.

I urge you to continue and discover why this could be the biggest winner of the
AI revolution.

Resume Video Read Transcript
 
✕


PLEASE ENTER YOUR EMAIL ADDRESS TO RESERVE YOUR SPOT WHILE WE PREPARE YOUR FREE
DOSSIER, “THE #1 AI STOCK: HOW TO RETIRE ON THIS OBSCURE UNDER $10 STOCK."